InsidersTradesSigma
Follow the Medicamen Organics share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are listed on the IN market, under the supervision of SEBI (PIT + SAST). Market capitalisation: €3.3bn. The latest transaction was disclosed on 19 June 2026 (Acquisition). Among the most active insiders: Pradeep Kumar Jain. All data is free.
2
Insider Decl.
n/a
Thresholds
n/a
2 ops.
Buy Volume
n/a
n/a
Sell Volume
Fundamental score
Ranked 19,213 of 29,064 companies
41.3
score / 100
Value31
Quality52
FCF yld-11%
Earn yld2.8%
EV/EBITDA17.5x
ROE4.0%
Gross mgn49%
Net mgn4.9%
Debt/EBITDA2.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 19 June 2026
Declarations2 total
2,000,000 sharesEquity sharesPreferential AllotmentSEBI:8bc45bc3cad2c47f27d5d6a320e70c9457c4b29a
Canonical exit: 17 Sept 2026 (T+90)
714,285 sharesEquity sharesPreferential AllotmentSEBI:0c3b8e32e4ae77a97e6b86e8eb4959943dafb752
Canonical exit: 17 Sept 2026 (T+90)
2 of 2 declarations
关于 Medicamen Organics
Medicamen Organics 是一家在孟买证券交易所上市的公司，专门从事药品制造。该公司专注于仿制药和创新配方的开发。